Efficacy of glimepiride/metformin fixed-dose combination vs metformin uptitration in type 2 diabetic patients inadequately controlled on low-dose metformin monotherapy: A randomized, open label, parallel group, multicenter study in Korea-Reference-Cited by-同舟云学术

Efficacy of glimepiride/metformin fixed-dose combination vs metformin uptitration in type 2 diabetic patients inadequately controlled on low-dose metformin monotherapy: A randomized, open label, parallel group, multicenter study in Korea

Published:2014-03-16 Issue:6 Volume:5 Page:701-708
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Invest

Author:

Kim Hye-soon¹,Kim Doo-man²,Cha Bong-soo³,Park Tae Sun⁴,Kim Kyoung-ah⁵,Kim Dong-lim⁶,Chung Choon Hee⁷,Park Jeong-hyun⁸,Jang Hak Chul⁹,Choi Dong-seop¹⁰

Affiliation:

1. Department of Internal Medicine; Keimyung University School of Medicine; Daegu Korea

2. Department of Internal Medicine; Hallym University College of Medicine; Seoul Korea

3. Department of Internal Medicine; Yonsei University College of Medicine; Seoul Korea

4. Department of Endocrinology and Metabolism; Chonbuk National University Hospital; Jeonju Korea

5. Department of Internal Medicine; Dongguk University College of Medicine; Goyang Korea

6. Department of Internal Medicine; Konkuk University School of Medicine; Seoul Korea

7. Department of Internal Medicine; Yonsei University Wonju College of Medicine; Wonju Korea

8. Paik Institute for Clinical Research; Department of Internal Medicine; College of Medicine; Inje University; Busan Korea

9. Department of Internal Medicine; Seoul National University Bundang Hospital; Seongnam Korea

10. Division of Endocrinology and Metabolism; Department of Internal Medicine; Korea University College of Medicine; Seoul Korea

Funder

Handok Inc.

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdi.12201/fullpdf

Reference31 articles.

1. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34);UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998

2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998

3. 10-year follow-up of intensive glucose control in type 2 diabetes;Holman;N Engl J Med,2008

4. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group;Turner;JAMA,1999

5. Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study;Hermann;Diabetes Care,1994

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Efficacy of Metformin and Glimepiride in Modulating Pharmacological Network to Increase BDNF Levels and Benefit Type 2 Diabetes-Related Cognitive Impairment;Biomedicines;2023-10-31

2. Association of SLC22A1, SLC47A1, and KCNJ11 polymorphisms with efficacy and safety of metformin and sulfonylurea combination therapy in Egyptian patients with type 2 diabetes;Research in Pharmaceutical Sciences;2023

3. Comparison of efficacy between canagliflozin and teneligliptin as add-on therapy to metformin and glimepiride on plasma glucose levels along with blood pressure and lipid levels in patients with type 2 diabetes mellitus;Journal of Diabetology;2023

4. Genetic Variants Associated with Poor Responsiveness to Sulfonylureas in Filipinos with Type 2 Diabetes Mellitus;Journal of the ASEAN Federation of Endocrine Societies;2022-06-16

5. Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales;Frontiers in Pharmacology;2022-01-19